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Similar to several other viruses, human T cell leukemia virus type I (HTLV-I) induces the formation of multinucleated giant cells (also
known as syncytium) when amplified in tissue culture. These syncytia result from the fusion of infected cells with uninfected cells. Due to the
intrinsic difficulty of infecting cells with cell-free HTLV-I virions, syncytium formation has become an important tool in the study of HTLV-I
infection and transmission. Since most HTLV-I-based cell fusion assays rely on the use of non-T cells, the aim of this study was to optimize a
new HTLV-I-induced cell fusion assay in which HTLV-I-infected T cell lines are co-cultured with T cells that have been transfected with an
HTLV-I long terminal repeat (LTR) luciferase reporter construct. We demonstrate that co-culture of various HTLV-I-infected T cells with
different transfected T cell lines resulted in induction of luciferase activity. Cell-to-cell contact and expression of the viral gp46 envelope
protein was crucial for this induction while other cell surface proteins (including HSC70) did not have a significant effect. This quantitative
assay was shown to be very sensitive. In this assay, the cell fusion-mediated activation of NF-nB and the HTLV-I LTR occurred through
previously described Tax-dependent signaling pathways. This assay also showed that cell fusion could activate Tax-inducible cellular
promoters. These results thus demonstrate that this new quantitative HTLV-I-dependent cell fusion assay is versatile, highly sensitive, and can
provide an important tool to investigate cellular promoter activation and intrinsic signaling cascades that modulate cellular gene expression.
D 2005 Elsevier Inc. All rights reserved.Keywords: HTLV-I; Cell fusion; Tax; LuciferaseIntroduction
HTLV-I is the etiological agent of adult T cell leukemia/
lymphoma (ATLL) and tropical spastic paraparesis (TSP)
also known as HTLV-I-associated myelopathy (HAM)
(Gessain et al., 1985; Osame et al., 1986; Poiesz et al.,0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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1 These authors contributed equally to this work.1980). Other documented complications associated with this
virus include uveitis, cutaneous lymphoma, arthritis, and
Sjo¨gren’s syndrome (Manns et al., 1999; Masuko-Hongo et
al., 2003; Watanabe, 1997). Although this virus is prevalent
in certain areas of Japan, very few infected individuals
(from 2% to 5%) develop symptoms associated with HTLV-
I infection. Furthermore, most of these associated diseases
take decades to develop following infection. Because of the
long clinical latency associated with HTLV-I infection, there
is a lack of information regarding the onset of these illnesses
as well as the mode of virus replication. However, it is
known that in vivo HTLV-I proviral DNA is predominately
found in CD4+ and CD8+ T cells (Richardson et al., 1990).05) 309 – 322
M.-E`. Pare´ et al. / Virology 338 (2005) 309–322310In cell culture, it appears that HTLV-I tropism extends to
other cell types or species of origin (Okuma et al., 1999;
Trejo and Ratner, 2000). Recent identification of the
putative HTLV-I receptor, the GLUT-1 glucose transporter,
may explain the ubiquitous nature of HTLV-I tropism in
vitro (Manel et al., 2003a).
It is well established that purified HTLV-I virions infect
susceptible cells very inefficiently (Derse et al., 2001; Fan et
al., 1992) and that transmission in cell culture is greatly
improved when cell-to-cell contact is allowed. HTLV-I-
infected cells undergo cell-to-cell fusion events (also termed
syncytia) in cell culture. Although their existence in vivo is
debatable, the importance of syncytia in HTLV-I infection
and the role of cell surface proteins in viral entry have been
well documented. As in viral infection, the viral gp46
glycoprotein mediates cell fusion by serving as the receptor
interacting molecule and allows subsequent exposure of the
fusion peptide to the viral gp21 transmembrane protein (Le
Blanc et al., 2001; Sommerfelt, 1999). In addition to
interaction of the cell receptor with gp46, other cellular
proteins are likely to contribute to syncytium formation. It has
been suggested that the heat shock cognate protein 70
(HSC70) might be an important player in HTLV-I-induced
syncytium formation (Sagara et al., 1998). Similar to anti-
gp46-blocking antibodies or sera from HTLV-I-seropositive
patients, antibodies against certain other molecules also
inhibit HTLV-I-induced syncytium formation (Daenke et al.,
1999; Nagy et al., 1983; Okuma et al., 1999). For example,
the use of antibodies against vascular cell adhesion molecule-
1 (VCAM-1) and major histocompatibility complex class II
(MHC-II) suggests that those molecules play a role in cell-to-
cell fusion (Hildreth, 1998; Hildreth et al., 1997).
The viral Tax protein is also likely to affect syncytium
formation. Tax has been clearly implicated in HTLV-I-
induced cell transformation (Nerenberg et al., 1987), as well
as playing a crucial role in HTLV-I replication. Indeed, Tax
enhances the binding of the CREB transcription factor to
elements in the HTLV-I LTR termed Tax responsive element
1 (TRE1) (Franklin et al., 1993; Zhao and Giam, 1992) and
also recruits CREB-binding protein (CBP) to these com-
plexes (Kwok et al., 1996). Because of its ability to activate
CREB as well as the transcription factors NF-nB and SRF
(Armstrong et al., 1993; Munoz and Israel, 1995; Yoshida,
1994), Tax is an important modulator of cellular gene
expression. Specifically, Tax modulates the expression of
cell adhesion molecules (Owen et al., 1997; Valentin et al.,
2001), which are important factors in HTLV-I-mediated
syncytium formation.
The study of HTLV-I-mediated syncytium formation
requires maintenance of typical cell adhesion molecule
interactions. Since several syncytium formation assays rely
on non-T cells, we sought to develop a new quantitative
system to evaluate HTLV-I-dependent syncytium formation
in T cell lines. Using an HTLV-I LTR-dependent luciferase
gene reporter system transfected into Jurkat T cells, we have
quantitated the extent of syncytium formation betweenHTLV-I-producing T cell lines and Jurkat T cells by
measuring luciferase activity. Our results show that this
assay is very sensitive and provides a useful tool to study
Tax-dependent modulation of cellular gene expression. The
results further suggest that HSC70 is not important in this
syncytium formation assay.Results
Induction of HTLV-I LTR activity by co-cultured MT2 cells
Several assays have been designed to evaluate HTLV-I
infection or HTLV-I-mediated cell-to-cell fusion events
(Daenke et al., 1999; Igakura et al., 2003; Okuma et al.,
1999). With this in mind, we wanted to develop a sensitive
and quantitative method to evaluate HTLV-I-dependent cell
fusion events that would exclusively involve T-cell-derived
lines. This is an important feature of our assay since T
lymphocytes are considered to be the primary cell type to
harbor HTLV-I proviral DNA in vivo (Richardson et al.,
1990). We reasoned that cell fusion in T lymphocytes might
be easily quantitated using a construct containing the HTLV-
I LTR regulating expression of the luciferase reporter gene
(pHTLV-Luc). Hence, transfected cells that fuse with
HTLV-I-infected cells should produce higher luciferase
activity due to transactivation by the Tax protein provided
by the infected cells.
To test whether co-culture could upregulate luciferase
activity in T cells, we first incubated MT2 cells, which
actively produce HTLV-I particles, with Jurkat cells that had
been transfected with the pHTLV-Luc plasmid. Luciferase
activity was measured at different time points following
incubation. As presented in Fig. 1A, the addition of MT2
cells to pHTLV-Luc-transfected Jurkat cells resulted in a
time-dependent induction of luciferase activity that reached
a 48-h optimum of 114-fold and then diminished after 72 h
of incubation. Induction of luciferase activity was detected
as early as 8 h following co-culture, suggesting that the
mechanism of induction involved cell-to-cell fusion pro-
cesses as opposed to infection, which would require a
longer time. To confirm these results, Jurkat cells trans-
fected with pHTLV-Luc were cultivated for 24 h in the
presence of HTLV-I-infected T cell lines producing viral
particles (MT2) or not (C8166-45 and MT4). As shown
above, the MT2 cell line induced luciferase activity, while
the other non-producing cell lines had no effect on
luciferase activity (Fig. 1B). To further confirm the ability
of HTLV-I-infected cells to induce luciferase expression in
uninfected cells, two additional HTLV-I-infected cell lines
(MJ and C91/PL) were co-cultured with Jurkat cells that
had been transfected with pHTLV-Luc (Fig. 1C). Increased
luciferase activity was again observed following co-culture
with both cell types although at the level of luciferase
activation was variable. Although co-culture with C91/PL
cells resulted in the greatest induction of luciferase activity,
Fig. 1. Activation of NF-nB- and HTLV-I LTR-dependent luciferase expression in transfected T cell lines cultured in the presence of HTLV-I-infected cells. (A)
Jurkat cells were transfected with 15 Ag of pHTLV-Luc and cultured in the presence or absence of equal number of MT2 cells for 8, 24, 48, or 72 h. (B, C)
Jurkat cells transfected with pHTLV-Luc were cultured in the presence or absence of equal number of MT2, MT4 C8166-45, or C91/PL cells for 24 h. Co-
culture experiments were also conducted with equal numbers of 293T cells transfected with 5 Ag of pSV2gpt, K30, or ACH. (D) Jurkat cells were transfected
with 15 Ag of pHTLV-Luc, pNF-nB-Luc, pnBTATA-Luc, or pNFAT-Luc and co-cultured in the presence or absence of equal number of MT2 cells for 24 h. (E)
Jurkat, SupT1, J45.01, and J.RT3 cells were transfected with 15 Ag of pHTLV-Luc and cultured in the presence or absence of equal number of MT2 cells for 24
h. Cells were lysed and then evaluated for luciferase activity as described in Materials and methods. Values are the mean of 3 different measured samples TSD.
(B, C) Fold inductions were calculated as the mean value of transfected cells cultured in the presence of HTLV-I-infected cells divided by the mean value of
transfected cells alone. (C) Fold inductions for transfected 293T cells were calculated as the mean value of co-cultured ACH- or K30-transfected cells divided
by the mean value of pSV2gpt-transfected cells. (B–E) Luciferase activities and fold activation are presented on a logarithmic scale. This is representative of 3
independent experiments.
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their high degree of variation between experiments (171 T
82-fold). Co-culture of transfected Jurkat cells with 293T
cells that had been transfected with two different HTLV-I
proviral DNA clones (i.e., K30 or ACH) resulted in greater
luciferase activity than when transfected Jurkat cells were
co-cultured with 293T cells transfected with the empty
vector.
Activation of the HTLV-I LTR by Tax involves the
CREB transcription factor; however, Tax can also activate
the NF-nB transcription factor. Therefore, we reasoned
that cell-to-cell fusion should also induce NF-nB-depend-
ent luciferase gene expression in Jurkat cells. Transfection
of Jurkat cells with the pNF-nB-Luc reporter followed by
culture in the presence of MT2 cells resulted in a rapid
and strong induction of luciferase activity, similar to that
observed with pHTLV-Luc (Fig. 1D). Similar results were
obtained upon co-culture of MT2 cells with the Jurkat-
derived JnB cell line (Ouellet et al., 1999), whichcontains a stably integrated pNF-nB-Luc (data not
shown). Co-culture of MT2 cells with Jurkat cells
transfected with the pnBTATA-Luc vector, which contains
NF-nB-binding sites derived from the HIV-1 enhancer,
also resulted in strong induction of luciferase activity. In
contrast, co-culture of Jurkat cells transfected with
pNFAT-Luc, which is poorly Tax responsive in Jurkat
cells (data not shown), did not lead to a significant
increase in luciferase activity.
To determine whether other T cell lines could be used in
this system, SupT1 and Jurkat-derived J.RT3 and J45.01
cells were transfected with pHTLV-Luc and cultured in the
presence of MT2 cells. MT2-dependent activation of luci-
ferase gene expression was again observed in all of the
transfected T cell lines (Fig. 1E), although variations were
noted among the different cell lines tested. These results
demonstrate that co-culture with HTLV-I-producing cells
leads to activation of the HTLV-I LTR in various T cell
lines. These data further suggest that a cell fusion-dependent
Fig. 2. Implication of cell contact in the MT2-mediated induction of HTLV-
I LTR activity in Jurkat cells. Jurkat cells were transfected with 15 Ag of
pHTLV-Luc. (A) Transfected Jurkat cells were cultured in the presence of
equal number of MT2 cells or supernatants harvested from MT2 cells
cultured for 24 h. (B) Transfected Jurkat cells were co-cultured with MT2
cells in the presence of increasing concentrations of DEAE-Dextran or
dextran sulfate. (C) Transfected Jurkat cells were added to 24-well plates
and left unstimulated, stimulated with bpV[pic] (10 AM), or co-cultured
with an equal number of MT2 cells. In some wells, Falcon cell culture insert
into which RPMI medium, bpV[pic] (10 AM), or equal MT2 cell number
were added overlaid untreated transfected Jurkat cells. Cells were lysed
after 24 h and measured for luciferase activities except, in (C) where cell
samples were also lysed and measured after 8 h. Depicted luciferase
activities are the mean of 3 different measured samples TSD. (C) Luciferase
activities are presented on a logarithmic scale. These experiments are
representative of 3 independent experiments.
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of luciferase gene expression.
Direct contact between cells is necessary for increased
intercellular luciferase activity
As suggested above, given the short length of time
required to induce HTLV-I LTR activity in Jurkat cells, cell
fusion events triggered by co-culture with MT2 cells are
likely the determining events in this upregulation of
luciferase gene expression. However, soluble factors
released from MT2 cells (for example, Tax) might also
contribute to HTLV-I LTR activity.
To demonstrate that cell fusion events were required to
modulate luciferase activity, we investigated the importance
of cell-to-cell contact in this process. Specifically, the
luciferase activity from co-cultures of pHTLV-Luc-trans-
fected Jurkat cells with MT2 cells was compared to
transfected Jurkat cells cultured with cell-free MT2 super-
natant (Fig. 2A). Co-culture with MT2 cells again increased
luciferase activity in transfected Jurkat cells, while cell-free
MT2 supernatant did not affect luciferase activity. To further
establish the requirement for cell-to-cell contact, co-cultured
cells were incubated in the presence of dextran sulfate, a
highly charged molecule that blocks cell fusion by causing
repulsion of cells from one another (Fig. 2B). DEAE-
dextran was used as a control because it has a reduced
ability to block cell fusion. Both of these agents were added
to the medium of Jurkat and MT2 co-cultures at subcyto-
toxic concentrations (i.e., 100 Ag/ml or lower). The addition
of dextran sulfate to Jurkat and MT2 co-cultures resulted in
a gradual but significant decrease in luciferase activity with
a maximal reduction of 93%. High DEAE-dextran concen-
trations had minimal effects on luciferase activity in these
co-cultures. No decrease in luciferase activity was observed
when transfected Jurkat cells alone were treated with similar
concentrations of dextran sulfate (data not shown).
To confirm the importance of cell contact between MT2
and transfected Jurkat cells in the induction in luciferase
activity, we used Falcon inserts containing a chamber with a
membrane allowing exclusive diffusion of low molecular
weight molecules (Fig. 2C). Jurkat cells were positioned in
the bottom of the well and MT2 cells were added to the
insert chamber, which was then placed in the well. As a
control, Jurkat cells were directly co-cultured in wells with
MT2 cells. To determine whether the insert itself affected
HTLV-I LTR activity in Jurkat cells, bpV[pic], a phospho-
tyrosine phosphatase (PTP) inhibitor, which we have
previously demonstrated to be a powerful activator of
HTLV-I transcription (Langlois et al., 2004), was added to
the insert chamber overlaying transfected Jurkat cells.
Luciferase activity was determined after 8 and 24 h of
incubation at these different experimental settings. We first
demonstrated that addition of bpV[pic] to the insert
activated the HTLV-I LTR in Jurkat cells to levels
comparable with those observed in cells treated directlywith the PTP inhibitor. In contrast, the increased luciferase
activity observed in pHTLV-Luc-transfected Jurkat cells
directly co-cultured with MT2 cells was attenuated in the
insert and luciferase activity returned to basal level (trans-
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cells were added to transfected Jurkat cells, a greater
increase in luciferase activity was observed, as expected.
Addition of MT2 cells and bpV[pic] to an insert overlaying
transfected Jurkat cells resulted in decreased luciferase
activity, similar to luciferase activity measured in
bpV[pic]-treated Jurkat cells in the absence of MT2 cells.
Overall, these results strongly suggest that modulation of
HTLV-I LTR activity observed in co-cultures depends on a
fusion event between MT2 and Jurkat cells.
HTLV-I-specific fusion events are required for HTLV-I LTR
activation
Since cell fusion is necessary for the increase in HTLV-I
LTR activity, we next asked whether simple fusion events
were sufficient to augment luciferase activity independent of
possible intercellular transfer of Tax protein. Jurkat cells
were transfected with either the pLTRX-Luc or pHTLV-Luc
plasmids, containing the HIV-1 and HTLV-I LTRs, respec-
tively. These cells were then co-cultured with cells chroni-
cally infected with HIV-1 (H9HIVIIIB) or HTLV-I (MT2)
(Fig. 3). As demonstrated above, co-culture of MT2 cells
with Jurkat cells transfected with the pHTLV-Luc plasmid
(panel A) resulted in a time-dependent increase in luciferase
activity. Consistent with the fact that the HIV-1 Tat protein
does not activate the HTLV-I LTR, no such increase was
observed following co-culture with the HIV-1-infectedFig. 3. Specificity of HTLV-I-mediated cell fusion event in the induction of
HTLV-I LTR activity. Jurkat cells were transfected with 15 Ag of pHTLV-
Luc (A) or pLTRX-Luc (B). Transfected Jurkat cells were subsequently
cultured alone or in the presence of an equal number of MT2 or H9HIVIIIB
cells. Cells were lysed 8, 24, and 48 h following co-culture and cell extracts
were measured for luciferase activity. Luciferase activities were measured
as the mean of 3 different measured samples TSD. Fold inductions were
calculated as the mean value of transfected cells cultured in the presence of
infected cells divided by the mean value of transfected cells alone. This
experiment is representative of 2 independent experiments.H9HIVIIIB cell line. Syncytium formation was nonetheless
visually observed in these co-cultures. Co-cultures of Jurkat
cells transfected with pLTRX-Luc (panel B) formed
syncytia, which paralleled the ability of H9HIVIIIB cells to
induce luciferase activity via the HIV-1 Tat protein (Barbeau
et al., 1998). MT2 cells were also able to increase luciferase
activity in these transfected Jurkat cells, which is attributed
to Tax-dependent activation of the HIV-1 LTR through NF-
nB. These results demonstrate that HTLV-I-specific fusion
events account for the increased luciferase activity in our co-
culture assay and that simple fusion events are not sufficient
to induce HTLV-I-LTR activity.
Increased luciferase activity is blocked by anti-gp46
antibodies
To clearly address the involvement of HTLV-I-dependent
cell fusion in the activation of luciferase activity in our co-
cultures, we used an anti-gp46 antibody (LAT 27), which
has been shown to neutralize both gp46-dependent syncy-
tium formation and HTLV-I infection (Tanaka et al., 1991).
Addition of increasing concentrations of the antibody to co-
cultures of pHTLV-Luc-transfected Jurkat cells and MT2
cells reduced luciferase activity up to 94% at the highest
concentration tested (20 Ag/ml) (Fig. 4A). Luciferase
activity was not affected when transfected Jurkat cells were
incubated in the presence of equal antibody concentrations.
Blocking experiments were also performed with other anti-
gp46 antibodies known to diminish cell fusion (0.5a
monoclonal antibody or SP-2, 3/4A antiserum) (Matsushita
et al., 1986; Palker et al., 1992). Incubation of co-cultured
cells with these antibodies reduced luciferase activity, albeit
to a lesser degree than LAT 27 (Fig. 4B).
Previous data suggested that the HSC70 cell surface
protein may mediate cell-to-cell fusion events (Fang et al.,
1999; Sagara et al., 1998, 2000). Given the importance of
this phenomenon, we used our cell fusion assay to
determine whether Jurkat cells depended on HSC70
expression to fuse with MT2 cells. LAT 27- or SPA815
(anti-HSC70)-blocking antibodies were added to co-culture
experiments and, as a control, SIM.2 (anti-CD4) antibodies
were also tested (Fig. 4C). Increasing concentrations of
either anti-CD4 or anti-HSC70 antibodies had no effect on
cell fusion-dependent induction of luciferase activity while
LAT 27 strongly diminished the induction of luciferase
activity. These results were not surprising since, similar to
the study of Brighty and Jassal (2001), HSC70 proteins
were not observed on the surface of our Jurkat clone by
FACS analysis (data not shown). Blocking antibodies
against MHC class I and ICAM-1, two cell surface proteins
that have been implicated in HTLV-I-mediated syncytium
formation (Daenke et al., 1999; Furuse et al., 1992), were
also tested in this assay and did not cause a statistically
significant diminution of luciferase activity (data not
shown). These data indicated that HSC70 and other
molecules previously implicated in syncytium formation
Fig. 4. Blocking anti-gp46 antibodies inhibit MT2-dependent activation of HTLV-I LTR. Jurkat cells (A–C) or isolated PBMCs (D) were transfected with 15
Ag of pHTLV-Luc and cultured in the presence or absence of an equal number of MT2 cells for 24 h (72 h for transfected PBMCs). (A) Increasing
concentrations of LAT 27 antibodies (0.625, 1.25, 2.5, 5, 10, and 20 Ag/ml) were added to transfected Jurkat cells incubated alone or in the presence of MT2
cells. (B) LAT 27 antibodies were added at 20 Ag/ml while SP2/3 and 0.5a antibodies were added at a 1:100 dilution. (C) Increasing concentrations of anti-
gp46 (LAT 27), anti-HSC70 (SPA815), or anti-CD4 (SIM.2) antibodies (5, 10 and 20 Ag/ml) were added to co-cultured cells. (D) LAT 27 was added at a
concentration of 20 Ag/ml to certain wells containing co-cultured PBMCs at a 1:1 or 1:2 ratio. Cells were lysed and assessed for luciferase activity. Depicted
luciferase activities are the mean of 3 different measured samples TSD. This experiment is representative of 3 independent experiments.
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cell-to-cell fusion as determined using our quantitative
syncytium formation assay.
To assess the importance of cell fusion in modulating
HTLV-I LTR activity in a more physiologically relevant
system, PBMCs were transfected with pHTLV-Luc and co-
cultured with MT2 cells at two different ratios. As expected,
luciferase activity was increased in co-cultured PBMCs at
both tested cell ratios (Fig. 4D). Importantly, this induction
was abrogated when the anti-gp46 antibody LAT 27 was
added to the culture. These results demonstrated that MT2
cell-dependent induction of HTLV-I LTR activity occurred
in PBMCs and was blocked by anti-gp46 antibodies. Cell
surface proteins previously thought to be important for
HTLV-I-mediated syncytium formation did not significantly
contribute to cell fusion in our assay.
Sensitivity of the quantitative HTLV-I-mediated cell fusion
assay
To determine the sensitivity of our quantitative HTLV-I-
mediated cell fusion assay, decreasing numbers of MT2cells were incubated in the presence of Jurkat cells trans-
fected with pHTLV-Luc or pNF-nB-Luc plasmids (Fig. 5).
After 24 h of co-culture, it was observed that in general,
incubation of as few as 4  102 MT2 cells in the presence of
105 Jurkat cells (ratio MT2/Jurkat 1:256) was sufficient to
confer a measurable augmentation of the luciferase signal
driven by the HTLV-I LTR (Fig. 5A). This signal increased
with the number of added MT2 cells up to a 1:32 cell ratio.
A similar trend was observed in Jurkat cells transfected with
the pNF-nB-Luc plasmid, where as few as 2  102 MT2
cells per 105 Jurkat cells (1:512) caused a statistically
significant increase in luciferase activity (Fig. 5B). These
results demonstrated that the present cell fusion assay is
very sensitive and requires a low number of infected cells
for activation to be measured.
CREB-binding sites within the HTLV-I LTR are required to
induce luciferase activity
We next used this quantitative cell fusion assay to
confirm the Tax-dependent mechanism of HTLV-I LTR
activation. Previous studies have clearly shown that CREB-
Fig. 5. Sensitivity of the HTLV-I-mediated cell fusion assay. Jurkat cells
were transfected with 15 Ag of pHTLV-Luc (A) or pNF-nB-Luc (B).
Transfected Jurkat cells were subsequently cultured alone or with two-fold
dilutions of the number of added MT2 cells (ratios of 1:1024, 1:512, 1:256,
1:128, 1:64, 1:32, 1:16, 1:8, 1:4, 1:2, and 1:1). Cells were lysed 24 h
following co-culture and cell extracts were measured for luciferase activity.
Depicted luciferase activities are the mean of 3 different measured samples
TSD. Fold induction for each cell ratio is indicated above each column. This
experiment is representative of 3 independent experiments.
Fig. 6. The CREB-binding sites in the TRE1 repeats are required for HTLV-
I LTR activation following co-culture. (A) Jurkat cells were transfected with
15 Ag of pGL2tata HTLV(325/57) or pGL2-promoter HTLV(325/
57). Transfected cells were cultured alone or with two-fold dilutions of
the number of added MT2 cells (ratios of 1:64, 1:32, 1:16, 1:8, 1:4, 1:2, and
1:1). (B) Jurkat cells were transfected with 15 Ag of pGL3 U3R or pGL3
21PMD/11T. Transfected cells were cultured alone or with two-fold
dilutions of the number of added MT2 cells (ratios of 1:64, 1:32, 1:16,
1:8, 1:4, 1:2, and 1:1). Cells were lysed 24 h following co-culture and cell
extracts were measured for luciferase activity. Depicted luciferase activities
are the mean of 3 different measured samples TSD. This experiment is
representative of 3 independent experiments.
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Tax-mediated LTR activation. Therefore, we reasoned that
these elements played an important role in our assay. To test
this possibility, we used various HTLV-I LTR-containing
constructs in our assay. Luciferase reporter plasmids
containing an LTR-derived fragment with all three TRE1
repeats and either the minimal SV40 promoter or a TATA
box (pGL2-promoter HTLV(325/57) and pGL2tata
HTLV(325/57), respectively) were transfected into
Jurkat cells and co-cultured with the MT2 cells. The
addition of MT2 cells resulted in maximal 47-fold or 203-
fold increases in luciferase activity in Jurkat cells transfected
with pGL2-promoter HTLV(325/57) and pGL2tata
HTLV(325/57), respectively (Fig. 6A). To further
address the importance of TRE1 sequences in intercellular
LTR activation, Jurkat cells were transfected with LTR
constructs mutated at all three CREB-binding sites within
the TRE1 repeats (pGL3 21PMD/11T). These mutations
greatly attenuate Tax induction of HTLV-I LTR activity
(Langlois et al., 2004). Jurkat cells were transfected with the
wild-type pGL3 U3R construct or the TRE1-mutated pGL3
21PMD/11T construct and then co-cultured with various
numbers of MT2 cells for 24 h. Compared to the wild-type
LTR construct, the mutant LTR was much less responsive toactivation upon co-culture with MT2 cells (Fig. 6B). In fact,
upon co-culture, the calculated fold inductions in Jurkat
cells transfected with pGL3 21PMD/11T was less than 10%
when compared to fold inductions measured in pGL3 U3R-
transfected cells. In these experiments, luciferase activity
(including transfected Jurkat cells incubated alone) tended
to be higher than in experiments conducted with the
pHTLV-Luc vector (see, for example, Fig. 5A). However,
MT2-mediated induction of luciferase activity was compa-
rable. These results demonstrate that LTR activation induced
by MT2-dependent cell fusion was Tax-dependent and
regulated by the typical CREB-dependent mechanism of
HTLV-I LTR activation.
Use of the quantitative HTLV-I-driven cell fusion assay to
analyze Tax-dependent modulation of gene expression
Tax activation of various transcription factors and
cellular genes is an important feature of HTLV-I infection
and pathogenesis. We thus wanted to determine whether our
assay could be used to test mechanistic aspects of Tax-
Fig. 8. Induction of ICAM-1 and RANTES promoter activity upon co-
culture with MT2 cells. Jurkat cells were transfected with 15 Ag of
pGL1.3Luc (ICAM-1 promoter) or pRANTES0.9Luc. Transfected Jurkat
cells were subsequently cultured alone or with two-fold dilutions of the
number of added MT2 cells (ratios of 1:256, 1:128, 1:64, 1:32, 1:16, 1:8,
M.-E`. Pare´ et al. / Virology 338 (2005) 309–322316dependent gene regulation. We were first interested in
studying the direct activation of transcription factors by Tax.
To determine whether our assay would be suitable to
understand pathways involved in transcription factor acti-
vation, we analyzed the well-characterized activation of NF-
nB by Tax. Jurkat cells were co-transfected with pNF-nB-
Luc and a dominant-negative InBa mutant expression
vector (InBaSer32-36/Ala). This dominant-negative mutant
has been previously shown to block NF-nB activation by
being resistant to IKK-induced phosphorylation and ubiq-
uitin-mediated degradation (Sun et al., 1996). As controls,
the empty vector and wild-type InBa expression vectors
were independently transfected in Jurkat cells along with
pNF-nB-Luc. As depicted in Fig. 7A, addition of different
numbers of MT2 cells upregulated luciferase activity in all
transfected Jurkat cells. However, when compared to other
transfected Jurkat cells, induction of luciferase activity was
reduced in co-cultured Jurkat cells expressing the dominant-Fig. 7. InBa and NIK dominant-negative mutants block MT2-mediated NF-
nB activation. (A) Jurkat cells were co-transfected with 7.5 Ag of pNF-nB-
Luc and 7.5 Ag of pCMV4-HA (empty vector), pCMV4-HA-InBa WT, or
pCMV4-HA-InBa S32/36A. Transfected cells were cultured alone or with
two-fold dilutions of the number of added MT2 cells (ratios of 1:64, 1:32,
1:16, 1:8, 1:4, 1:2, and 1:1). (B) Jurkat cells were co-transfected with 7.5 Ag
of pNF-nB-Luc or pHTLV-LUC and 7.5 Ag of pRKmyc-HA (empty
vector), or pRKmyc NIK KK(429-430)AA. Transfected cells were cultured
alone or with two-fold dilutions of the number of added MT2 cells (ratios of
1:128, 1:64, 1:32, 1:16, 1:8, 1:4, 1:2, and 1:1). Cells were lysed 24 h
following co-culture and cell extracts were measured for luciferase activity.
Luciferase activities were calculated as the mean of 3 different measured
samples TSD. For each transfections and co-culture conditions, fold
inductions were obtained from the mean value of transfected cells cultured
in the presence of MT2 cells divided by the mean value of transfected cells
alone. This experiment is representative of 3 independent experiments.
1:4, 1:2, and 1:1). Cells were lysed 24 h following co-culture and cell
extracts were measured for luciferase activity. Depicted luciferase activities
are the mean of 3 different measured samples TSD. This experiment is
representative of 3 independent experiments.negative InBa mutant. To examine the role of previously
characterized mediators of Tax-dependent NF-nB activation
in our assay, an upstream effector was tested in our cell
fusion-based quantitative assay. Previous studies have
demonstrated the importance of NF-nB-inducing kinase
(NIK) in NF-nB activation as well as its role in Tax-
mediated activation (Geleziunas et al., 1998; Hiscott et al.,
1997). To confirm these findings Jurkat cells were trans-
fected with a dominant-negative NIK KKA mutant expres-
sion vector and pNF-nB-Luc. Regardless of the cell ratio
tested, expression of the dominant-negative NIK mutant
reduced NF-nB-dependent luciferase expression when
compared to Jurkat cells co-transfected with the empty
vector (Fig. 7B). No effect on MT2-mediated induction of
luciferase activity was observed in Jurkat cells co-trans-
fected with pHTLV-Luc or any of the dominant-negative
mutant expression vectors tested in Jurkat cells (Fig. 7B and
data not shown).
We also investigated whether Tax-dependent modulation
of cellular gene expression could be analyzed using our
system. To address this possibility, two genes known to be
activated by Tax, ICAM-1 and RANTES (Mori et al., 2004;
Owen et al., 1997), were studied. Constructs containing
either the human ICAM-1 or RANTES promoters posi-
tioned upstream of the luciferase gene were transfected into
Jurkat cells. Transfected Jurkat cells were cultured in the
presence of different MT2 cell concentrations. Addition of
MT2 cells clearly augmented luciferase activity in the
transfected Jurkat cells (Fig. 8). This increase was blocked
by the addition of anti-gp46 LAT 27 antibodies (data not
shown). These results indicated that cell fusion-induced NF-
nB activation occurred through the previously described
Tax-dependent pathway making this system useful in the
M.-E`. Pare´ et al. / Virology 338 (2005) 309–322 317study of Tax-mediated signal transduction pathways. Tax-
responsive cellular genes showed similar levels of activity in
our quantitative cell fusion assay.Discussion
Studies on HTLV-I-dependent syncytium formation have
been generally limited to non-T cell lines. However, since
most HTLV-I-infected cells in humans are T lymphocytes, a
more representative system to measure HTLV-I-induced cell
fusion events should utilize human T cell lines. In addition,
since microscopic quantitation of syncytia is not accurate,
we wanted to develop a sensitive, reproducible, and
quantitative enzymatic assay to measure HTLV-I-dependent
cell fusion events in T lymphocytes. The luciferase reporter
gene was most suitable for our assay due to the ease and
sensitivity of measuring its activity. Several systems have
been previously described to measure HTLV-I-induced
syncytium formation and the luciferase reporter gene has
been used with T7 RNA polymerase to quantitate syncytia
(Okuma et al., 1999). Our assay, which takes advantage of
intracellular Tax in HTLV-I-infected cells, is based on the
activation of a luciferase reporter gene under the control of a
Tax-inducible promoter (i.e., the HTLV-I LTR) following
fusion with HTLV-I-infected cells.
Our initial results demonstrated that NF-nB- and HTLV-I
LTR-dependent transcription was activated in Jurkat T cells
following co-culture with HTLV-I-infected cells (MT2, MJ,
and C91/PL) in a time-dependent fashion. The increased
luciferase activity was constant up to 48 h, and thus was
somewhat slower than the similarly designed HIV-1-based
syncytium assay. This might be due to lengthier time needed
for optimal fusion of HTLV-I-infected cells after which the
drop in luciferase activity likely represents syncytium-
induced cell death and loss of luciferase-expressing cells.
These results parallel the increase observed upon co-culture
with non-T 293T cells transfected with HTLV-I proviral
DNA. The low response of Jurkat cells to MJ cells is likely
due to low production of viral particles from this cell line as
compared to other HTLV-I-producing cell lines used in this
study (data not shown), which would make MJ less
fusogenic. Increased luciferase activity was not observed
when transfected Jurkat cells were co-cultured with HTLV-I-
infected non-producing MT4 and C8166-45 cell lines that
do not express gp46 on their surface. Luciferase gene
expression was also induced upon co-culture with other
transfected T cell lines suggesting that the observed
induction (especially as early as 8 h after co-culture)
depended on cell fusion and not on viral infection. Several
approaches were used to confirm that the upregulation of
luciferase gene expression resulted from cell fusion events.
We showed that cell-to-cell contact was required through the
use of Dextran sulfate and membrane inserts. These results
are consistent with the fact that supernatant from MT2 cells
did not efficiently induce HTLV-I LTR activity. This is animportant issue since extracellular Tax has been reported to
induce T cell activation and NF-nB translocation in T cell
lines or PBMCs (Lindholm et al., 1990; Marriott et al.,
1991). Using anti-gp46 antibodies, we demonstrated that the
induction depended on gp46-mediated cell fusion. However,
cell-to-cell fusion events were not sufficient to induce
HTLV-I LTR regulated luciferase gene expression as judged
by the use of a fusion competent HIV-1-infected cell line.
These data are consistent with an obligatory fusion step
between MT2 and Jurkat cells to activate the LTR.
Luciferase upregulation in transfected PBMCs was con-
firmed using co-culture experiments with MT2 cells. Since
these PBMCs were not stimulated by antigen, it is likely that
HTLV-I receptor expression was modest, as previously
reported (Manel et al., 2003b), thereby contributing to the
reduced MT2-dependent activation of luciferase expression
compared to transfected Jurkat cells.
In these experiments, we also tested antibodies against
various cell surface proteins known to be important for viral
infection or HTLV-I-mediated cell fusion. For example, anti-
HSC70 antibodies did not effectively block cell fusion
events as determined by luciferase activity. Although these
results contradict previous work suggesting that these
antibodies do block HTLV-I-mediated syncytium formation
(Fang et al., 1999; Sagara et al., 1998), a more recent study
was also unable to demonstrate the involvement of HSC70
in Jurkat-MT2 cell fusions (Brighty and Jassal, 2001).
Blocking antibodies against ICAM-1 also had no effect on
syncytium formation. This result also contradicts a report in
which ICAM-1 expression in K562 cells augmented
syncytium formation with MT2 cells (Daenke et al., 1999).
Anti-ICAM-1 antibodies have also been reported to block
syncytium formation in C91/PL/MOLT4 cell co-cultures
(Fukudome et al., 1992). These data reinforce the notion that
HTLV-I-induced cell fusion or syncytium formation should
be studied in T cell lines. These results also demonstrate the
utility of this quantitative cell fusion assay in testing
antibodies against specific membrane receptors to assess
their involvement in HTLV-I-mediated cell fusion.
Our results demonstrated that this assay was sensitive
and required a limited number of HTLV-I-infected cells to
measure incremental luciferase activity following co-culture
with MT2 cells. However, in general, the highest MT2/
Jurkat cell ratios led to lower induction of luciferase activity.
Although the explanation for this observation is unknown,
potential soluble factors (such as cell supernatant-associated
soluble gp46) produced by MT2 cells may block cell fusion
events. The lower sensitivity of the pNF-nB-dependent
signal might depend on other supernatant-associated soluble
factors that activate NF-nB. This would further justify the
use of pHTLV-Luc as the fusion indicator vector, as it is less
likely to be sensitive to these types of soluble factor-
mediated activation.
Dominant-negative mutant expression vectors and
TRE1-mutated HTLV-I LTR reporters suggested that LTR
activation following cell fusion occurred through a pathway
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activation. The ability of Tax to induce luciferase activity
was further illustrated by the absence of induction in
pNFAT-Luc-transfected cells, confirming our finding that
Jurkat cells transfected with this vector were not induced
following co-transfection of a Tax-expression vector (data
not shown). In addition, recent results from our group
demonstrated that induction of Tax expression in Jurkat-
derived JPX/9 cells increased luciferase expression when
these cells were co-cultured and induced to fuse with
pHTLV-Luc-transfected Jurkat cells (unpublished results).
Since Tax-regulated cellular genes were also activated in
this cell fusion assay, it could be a valuable tool for the
study of Tax-dependent cellular gene regulation. Our system
offers several advantages that makes it particularly well
suited for this type of study. First, the assay permits parallel
evaluation of Tax activation following co-culture of differ-
ent HTLV-I-infected cell lines with transfected cells,
although the fusogenic potential of each infected cell line
may vary. Second, although this assay depends on cell
fusion events, the signaling pathway appears to be
consistent and, as opposed to the use of Tax expression
vectors, the assay permits a more physiological analysis of
Tax-dependent activation in terms of intracellular Tax levels
and the presence of other HTLV-I proteins that may
positively or negatively impact Tax function. Third,
compared to transient transfection experiments, our assay
might abolish potential effects of dominant-negative
mutants on the promoter driving Tax expression.
In summary, we present a quantitative HTLV-I-mediated
cell fusion assay consisting exclusively of T cell lines. This
assay was found to be very sensitive and suitable for
different uninfected and infected T cell lines. Variable
induction of luciferase activity noted when different HTLV-
I-infected and non-infected cells were tested is likely
attributable to variable content of cellular and viral factors
in the two partner cell lines used in the syncytium assays.
However, experiments conducted with the same HTLV-I-
infected/non-infected cell partners showed reproducible
induction of luciferase activity. We are currently using this
assay to analyze Tax-mediated signal transduction pathways
and to test antibodies that may potentially block cell fusion.Materials and methods
Cell lines
Jurkat (clone E61) (Schneider et al., 1977) and SupT1
(Smith et al., 1984) CD4+ T lymphoid cell lines were
obtained from the American Type Culture Collection
(ATCC, Manassas, MD). Jurkat-derived J.RT3 (Morley et
al., 1988) and J45.01 (Koretsky et al., 1991) cell lines are
deficient for cell surface T cell receptor and CD45
expression, respectively, and were kindly provided by Dr.
R.T. Abraham (The Mayo Clinic, Rochester, MN) and Dr.A. Weiss (Howard Hughes Medical Center, San Francisco,
CA). JnB was derived from Jurkat cells stably transfected
with pNF-nB-Luc along with the pEFneo vector and has
been previously described (Ouellet et al., 1999). MT2
(Haertle et al., 1988), MT4 (Harada et al., 1985), C8166-45
(Salahuddin et al., 1983), and C91/PL (Popovic et al., 1983)
are all HTLV-I-infected T cell lines; however, only MT2 and
C91/PL are capable of producing infectious HTLV-I
particles. MT2, C91/PL, and C8166-45 cell lines were
derived from cord blood lymphocytes while MT-4 was
obtained directly from a patient with adult T cell leukemia.
H9HIVIIIB (Popovic et al., 1984) is an H9-derived cell line
chronically infected with HIV-1IIIB. The C91/PL cell line
was obtained from Dr. R. Sutton (Baylor College of
Medicine, Houston TX), while other infected cell lines
were provided by the NIH AIDS Research and Reference
Reagent Program (Rockville, MD). All cell lines were
maintained in RPMI-1640 complete culture medium sup-
plemented with 10% fetal bovine serum (FBS; Hyclone
Laboratories, Logan, UT), 2 mM glutamine, 100 U/ml
penicillin G, and 100 Ag/ml streptomycin and kept under
neomycin selection when needed. Peripheral blood mono-
nuclear cells (PBMCs) were isolated from blood samples
taken from healthy individuals by Ficoll-Hypaque density
gradient centrifugation. Isolated PBMCs were resuspended
in supplemented RPMI medium and directly used for
transfection.
Plasmids
pNF-nB-Luc is commercially available (Stratagene) and
harbors five NF-nB-binding sites along with a minimal
promoter upstream of the luciferase gene. The pnBTATA-
Luc vector was kindly provided by Dr. W.C. Greene (The J
Gladstone Institutes, San Francisco, CA) and contains the
luciferase reporter gene under the control of a minimal
promoter and the HIV-1 enhancer region (Sun et al., 1996).
The pNFAT-Luc vector contains the minimal IL-2 promoter
positioned downstream of three tandem copies of an NFAT-
binding site and was kindly provided by Dr. G. Crabtree
(Howard Hugues Medical School, Stanford CA) (Timmer-
man et al., 1996). The pHTLV-Luc vector (also kindly
provided by Dr. W.C. Greene) contains the complete HTLV-
I LTR 3V region cloned into the XhoI/HindIII site of the
pGL2-Basic luciferase vector (Promega) (Geleziunas et al.,
1998). The pGL3 U3R and pGL3 21PMD/11T plasmids
were both derived by cloning a wild-type LTR (U3R) or the
TRE1-mutated LTR (21PMD/11T) (Barnhart et al., 1997)
into the XhoI/HindIII sites of the pGL3-Basic vector. The
pGL2tata-Luc vector was constructed by subcloning a
synthetic double-stranded oligonucleotide containing a
TATA box and NheI/HindIII compatible ends (produced
by hybridizing 5V-CTAGCGGGTATATAATGGATCCA-3V
and 5V-AGCTTGGATCCATTATATACCCG-3Voligonucleo-
tides) into the similarly digested pGL2-Basic vector
(Promega). The pGL2tata HTLV(325/57) construct
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fragment from the HTLV-I LTR into the SmaI site of the
pGL2tata-Luc vector. A similar cloning procedure was used
to introduce the HTLV-I LTR fragment into the SmaI-
digested pGL2-promoter vector (Promega) generating
pGL2-promoter HTLV(325/57). The pLTRX-Luc con-
struct was generously provided by Dr. O. Schwartz (Pasteur
Institute, Paris) (Schwartz et al., 1990). Expression vectors
for the wild-type and mutated InBa protein (pCMV4-HA-
InBa WT or pCMV4-HA-InBa S32/36A, respectively), the
dominant-negative NIK mutant (pRKmyc NIK KK(429-
430)AA), and their corresponding empty vectors were
kindly provided by Dr. W.C. Greene (Geleziunas et al.,
1998; Sun et al., 1996). The luciferase reporter vectors
pGL1.3 and pRANTES0.9Luc are under the control of the
ICAM-1 and RANTES promoters, respectively, and were
kind gifts from Dr. M. Audette (Centre de recherche en
endocrinologie mole´culaire et oncologique, CHUQ, Pavil-
lon CHUL, Ste-Foy, Canada) and from Dr. A.S. Fauci
(National Institute of Allergy and Infectious Diseases,
Bethesda, MD) (Moriuchi et al., 1997; Roy et al., 2001).
Complete HTLV-I proviral DNA producing fully infectious
particles tested in the present study included K30 (Zhao et
al., 1995) (obtained from the NIH AIDS Research and
Reference Reagent Program, Rockville, MD) and ACH
(Kimata et al., 1994) (kindly provided by Dr. Jean-Michel
Mesnard, Laboratoires Infections Re´trovirales et Signal-
isation Cellulaire, CRBM-CNRS UPR 1086, Montpellier,
France). The pSV2gpt vector was derived from K30
following excision of the proviral DNA.
Antibodies and reagents
The LAT 27 monoclonal antibodies specific for the
HTLV-I gp46 envelope protein were derived from WKA
rats immunized with a recombinant vaccinia virus express-
ing the gp46 (Tanaka et al., 1991). Anti-Sp-2, 3/4A, and
0.5a antibodies specific for HTLV-I gp46 (Matsushita et al.,
1986; Palker et al., 1992) and SIM.2 anti-CD4 antibodies
(McCallus et al., 1992) were obtained from the NIH AIDS
Research and Reference Reagent Program (Rockville, MD).
The anti-HSC70 antibody, SPA815, was purchased from
Stressgen (Victoria, Canada). Anti-MHC class I W6/32
monoclonal antibodies (Barnstable et al., 1978) were
purified from the corresponding hybridoma (ATCC) super-
natant using mAbTrap protein G affinity columns (Pharma-
cia LKB Biotechnology AB, Uppsala, Sweden). The anti-
ICAM-1 RR1/1.1.1-blocking antibody was kindly provided
by Dr. Robert Rothlein (Boehringer Ingelheim, Ridgefield,
CT) (Rothlein et al., 1986). DEAE-Dextran was purchased
from Amersham Pharmacia Biotech while dextran sulfate
was purchased from Sigma. BpV[pic], a bis-peroxovana-
dium protein tyrosine phosphatase inhibitor, was kindly
provided by Dr. B.J. Posner (McGill University, Montreal,
Canada), and its preparation has been described previously
(Posner et al., 1994).Transfections
Transient transfections of T cell lines were performed
using the DEAE-Dextran method as previously described
(Barbeau et al., 1997). Briefly, 5  106cells were washed
in TS buffer (137 mM NaCl, 25 mM Tris–HCl [pH 7.4], 5
mM KCl, 0.6 mM Na2HPO4, 0.5 mM MgCl2, and 0.7 mM
CaCl2) and resuspended in 0.5 ml TS containing 15 Ag of
the indicated plasmid(s) and 500 Ag/ml DEAE-dextran
(final concentration). The cell/TS/plasmid/DEAE-dextran
mix was incubated for 25 min at room temperature.
Thereafter, cells were diluted to a concentration of 1 
106/ml using complete culture medium supplemented with
100 AM chloroquine (Sigma) and transferred into 6-well
plates. After a 45-min incubation at 37 -C, cells were
centrifuged, resuspended in complete culture medium, and
incubated at 37 -C for 24 h. Transfection of PBMCs was
performed as previously described (Hughes and Pober,
1996). Following isolation, cells were concentrated to 3 
106 cells/ml and stimulated with phytohemagglutinin-L for
19–20 h at 37 -C. Cells were then concentrated in
complete RPMI medium to 2  107 cells/ml and a 250-Al
aliquot was electroporated with 15 Ag pHTLV-Luc plasmid
in a 0.4-cm cuvette using a Bio-Rad electroporation device
(250 V, 950 AF). Transfection of 293T cells was conducted
as previously described. Briefly, cells were plated 16 h
before transfection to reach a 50–80% confluence the day
of transfection and transfected with 5 Ag of DNA using the
Clontech Transfection Kit (BD Biosciences). To minimize
variation in plasmid transfection efficiencies, cells were
transfected in bulk and were then separated into various
treatment groups.
Co-culture experiments
Infected and uninfected transfected cells were first
concentrated to 1  106 cells/ml. 1  105 uninfected cells
were then mixed with an equal number of HTLV-I-infected
cells (or in certain cases, HIV-1-infected cells) and
incubated for 8–72 h in 96-well plates. When different cell
ratios were tested, the 1  106 cell/ml concentration of
infected cells was diluted two-fold and 100 Al samples of
each dilution was added to 100 Al of Jurkat cells (1  105
cells). In some experiments, LAT 27, anti-Sp-2, 3/4A,
SIM.2, DEAE-Dextran, or Dextran Sulfate were added to
the co-cultured cells at the indicated concentrations. As a
control, transfected Jurkat cells were incubated alone or
with an equal volume of MT2 supernatant harvested from
1  106 MT2 cell/ml incubated for 24 h. For all
experiments, co-cultured cells were lysed and luciferase
activity was assessed with a microplate luminometer (MLX;
Dynex Technologies, Chantilly, VA) as previously described
(Barbeau et al., 1997; Cantin et al., 1997; Fortin et al.,
1997). Mean luciferase activity T standard deviation (SD)
was calculated using luciferase activity from three inde-
pendent and similarly treated co-cultured cell samples.
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Cells were mixed in Falcon cell culture inserts containing
a chamber separated from the wells by a 0.4-AM membrane
(Becton Dickinson, Franklin Lakes, NJ). Cells were initially
concentrated to 1  106 cells/ml. MT2 cells or an equal
volume of medium (750 Al) was subsequently added onto the
membrane of the chamber, which was inserted into a well of
a 24-well plate containing an equal number of pHTLV-Luc-
transfected Jurkat cells. In certain samples, bpV[pic] (10
AM) was also added in the upper chamber of the insert. As a
control, a similar number of MT2 and transfected Jurkat cells
were directly co-cultured in 24-well plates without an insert.
After 24, 48, or 72 h of incubation, 100 Al of transfected
Jurkat cells was withdrawn from each condition and assessed
for luciferase activity as described above.Acknowledgments
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